Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 10, 2016, Pages 2004-2014

  Kamelgarn, Marisa ^a   Chen, Jing ^a   Kuang, Lisha ^a   Arenas, Alexandra ^a   Zhai, Jianjun ^a   Zhu, Haining ^a,b   Gal, Jozsef ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

ALS; FUS; Neurodegeneration; Protein interaction network; Proteomics

Indexed keywords

FUSED IN SARCOMA PROTEIN; MATRIN 3 PROTEIN; RIBONUCLEOPROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN CELL; CHROMOSOME STRUCTURE; EMBRYO; EXOSOME; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; LOSS OF FUNCTION MUTATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEOMICS; RNA SPLICING; RNA TRANSPORT;

EID: 84981352019     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2016.07.015     Document Type: Article

References (84)

1. [1] Walling, A.D., Amyotrophic lateral sclerosis: Lou Gehrig's disease. Am. Fam. Physician 59 (1999), 1489–1496.
2. [2] Wijesekera, L.C., Leigh, P.N., Amyotrophic lateral sclerosis. Orphanet J. Rare Dis., 4, 2009, 3.
3. [3] Kwiatkowski, T.J. Jr., Bosco, D.A., Leclerc, A.L., Tamrazian, E., Vanderburg, C.R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E.J., Munsat, T., Valdmanis, P., Rouleau, G.A., Hosler, B.A., Cortelli, P., de Jong, P.J., Yoshinaga, Y., Haines, J.L., Pericak-Vance, M.A., Yan, J., Ticozzi, N., Siddique, T., McKenna-Yasek, D., Sapp, P.C., Horvitz, H.R., Landers, J.E., Brown, R.H. Jr., Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323 (2009), 1205–1208.
4. [4] Vance, C., Rogelj, B., Hortobagyi, T., De Vos, K.J., Nishimura, A.L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., Ganesalingam, J., Williams, K.L., Tripathi, V., Al-Saraj, S., Al-Chalabi, A., Leigh, P.N., Blair, I.P., Nicholson, G., de Belleroche, J., Gallo, J.M., Miller, C.C., Shaw, C.E., Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323 (2009), 1208–1211.
5. [5] DeJesus-Hernandez, M., Kocerha, J., Finch, N., Crook, R., Baker, M., Desaro, P., Johnston, A., Rutherford, N., Wojtas, A., Kennelly, K., Wszolek, Z.K., Graff-Radford, N., Boylan, K., Rademakers, R., De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Hum. Mutat. 31 (2010), E1377–E1389.
6. [6] Belzil, V.V., Valdmanis, P.N., Dion, P.A., Daoud, H., Kabashi, E., Noreau, A., Gauthier, J., S.D. team, Hince, P., Desjarlais, A., Bouchard, J.P., Lacomblez, L., Salachas, F., Pradat, P.F., Camu, W., Meininger, V., Dupre, N., Rouleau, G.A., Mutations in FUS cause FALS and SALS in French and French Canadian populations. Neurology 73 (2009), 1176–1179.
7. [7] Corrado, L., Del Bo, R., Castellotti, B., Ratti, A., Cereda, C., Penco, S., Soraru, G., Carlomagno, Y., Ghezzi, S., Pensato, V., Colombrita, C., Gagliardi, S., Cozzi, L., Orsetti, V., Mancuso, M., Siciliano, G., Mazzini, L., Comi, G.P., Gellera, C., Ceroni, M., D'Alfonso, S., Silani, V., Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. J. Med. Genet. 47 (2010), 190–194.
8. [8] Andersson, M.K., Stahlberg, A., Arvidsson, Y., Olofsson, A., Semb, H., Stenman, G., Nilsson, O., Aman, P., The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol., 9, 2008, 37.
9. [9] Zinszner, H., Sok, J., Immanuel, D., Yin, Y., Ron, D., TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J. Cell Sci. 110:Pt 15 (1997), 1741–1750.
10. [10] Baechtold, H., Kuroda, M., Sok, J., Ron, D., Lopez, B.S., Akhmedov, A.T., Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation. J. Biol. Chem. 274 (1999), 34337–34342.
11. [11] Mastrocola, A.S., Kim, S.H., Trinh, A.T., Rodenkirch, L.A., Tibbetts, R.S., The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage. J. Biol. Chem. 288 (2013), 24731–24741.
12. [12] Wang, W.Y., Pan, L., Su, S.C., Quinn, E.J., Sasaki, M., Jimenez, J.C., Mackenzie, I.R., Huang, E.J., Tsai, L.H., Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat. Neurosci. 16 (2013), 1383–1391.
13. [13] Wang, X., Arai, S., Song, X., Reichart, D., Du, K., Pascual, G., Tempst, P., Rosenfeld, M.G., Glass, C.K., Kurokawa, R., Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 454 (2008), 126–130.
14. [14] Tan, A.Y., Manley, J.L., TLS inhibits RNA polymerase III transcription. Mol. Cell. Biol. 30 (2010), 186–196.
15. [15] Du, K., Arai, S., Kawamura, T., Matsushita, A., Kurokawa, R., TLS and PRMT1 synergistically coactivate transcription at the survivin promoter through TLS arginine methylation. Biochem. Biophys. Res. Commun. 404 (2011), 991–996.
16. [16] Haile, S., Lal, A., Myung, J.K., Sadar, M.D., FUS/TLS is a co-activator of androgen receptor in prostate cancer cells. PLoS One, 6, 2011, e24197.
17. [17] Tan, A.Y., Riley, T.R., Coady, T., Bussemaker, H.J., Manley, J.L., TLS/FUS (translocated in liposarcoma/fused in sarcoma) regulates target gene transcription via single-stranded DNA response elements. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 6030–6035.
18. [18] Schwartz, J.C., Ebmeier, C.C., Podell, E.R., Heimiller, J., Taatjes, D.J., Cech, T.R., FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2. Genes Dev. 26 (2012), 2690–2695.
19. [19] Fujioka, Y., Ishigaki, S., Masuda, A., Iguchi, Y., Udagawa, T., Watanabe, H., Katsuno, M., Ohno, K., Sobue, G., FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD. Sci. Rep., 3, 2013, 2388.
20. [20] Bronisz, A., Carey, H.A., Godlewski, J., Sif, S., Ostrowski, M.C., Sharma, S.M., The multifunctional protein fused in sarcoma (FUS) is a coactivator of microphthalmia-associated transcription factor (MITF). J. Biol. Chem. 289 (2014), 326–334.
21. [21] Dhar, S.K., Zhang, J., Gal, J., Xu, Y., Miao, L., Lynn, B.C., Zhu, H., Kasarskis, E.J., Clair, D.K. St, FUsed in sarcoma is a novel regulator of manganese superoxide dismutase gene transcription. Antioxid. Redox Signal. 20 (2014), 1550–1566.
22. [22] Yang, L., Gal, J., Chen, J., Zhu, H., Self-assembled FUS binds active chromatin and regulates gene transcription. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 17809–17814.
23. [23] Uranishi, H., Tetsuka, T., Yamashita, M., Asamitsu, K., Shimizu, M., Itoh, M., Okamoto, T., Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator. J. Biol. Chem. 276 (2001), 13395–13401.
24. [24] Yang, L., Embree, L.J., Tsai, S., Hickstein, D.D., Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J. Biol. Chem. 273 (1998), 27761–27764.
25. [25] Dichmann, D.S., Harland, R.M., fus/TLS orchestrates splicing of developmental regulators during gastrulation. Genes Dev. 26 (2012), 1351–1363.
26. [26] Fujii, R., Takumi, T., TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J. Cell Sci. 118 (2005), 5755–5765.
27. [27] Fujii, R., Okabe, S., Urushido, T., Inoue, K., Yoshimura, A., Tachibana, T., Nishikawa, T., Hicks, G.G., Takumi, T., The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr. Biol. 15 (2005), 587–593.
28. [28] Sephton, C.F., Tang, A.A., Kulkarni, A., West, J., Brooks, M., Stubblefield, J.J., Liu, Y., Zhang, M.Q., Green, C.B., Huber, K.M., Huang, E.J., Herz, J., Yu, G., Activity-dependent FUS dysregulation disrupts synaptic homeostasis. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), E4769–E4778.
29. [29] Morlando, M., Dini Modigliani, S., Torrelli, G., Rosa, A., Di Carlo, V., Caffarelli, E., Bozzoni, I., FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J. 31 (2012), 4502–4510.
30. [30] Dini Modigliani, S., Morlando, M., Errichelli, L., Sabatelli, M., Bozzoni, I., An ALS-associated mutation in the FUS 3′-UTR disrupts a microRNA-FUS regulatory circuitry. Nat. Commun., 5, 2014, 4335.
31. [31] Bosco, D.A., Lemay, N., Ko, H.K., Zhou, H., Burke, C., Kwiatkowski, T.J. Jr., Sapp, P., McKenna-Yasek, D., Brown, R.H. Jr., Hayward, L.J., Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum. Mol. Genet. 19 (2010), 4160–4175.
32. [32] Gal, J., Zhang, J., Kwinter, D.M., Zhai, J., Jia, H., Jia, J., Zhu, H., Nuclear localization sequence of FUS and induction of stress granules by ALS mutants. Neurobiol. Aging 32:2323 (2011), e2327–e2340.
33. [33] Ito, D., Seki, M., Tsunoda, Y., Uchiyama, H., Suzuki, N., Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ann. Neurol. 69 (2011), 152–162.
34. [34] Dormann, D., Rodde, R., Edbauer, D., Bentmann, E., Fischer, I., Hruscha, A., Than, M.E., Mackenzie, I.R., Capell, A., Schmid, B., Neumann, M., Haass, C., ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 29 (2010), 2841–2857.
35. [35] Urwin, H., Josephs, K.A., Rohrer, J.D., Mackenzie, I.R., Neumann, M., Authier, A., Seelaar, H., Van Swieten, J.C., Brown, J.M., Johannsen, P., Nielsen, J.E., Holm, I.E., Consortium, F.R., Dickson, D.W., Rademakers, R., Graff-Radford, N.R., Parisi, J.E., Petersen, R.C., Hatanpaa, K.J., White, C.L. III, Weiner, M.F., Geser, F., Van Deerlin, V.M., Trojanowski, J.Q., Miller, B.L., Seeley, W.W., van der Zee, J., Kumar-Singh, S., Engelborghs, S., De Deyn, P.P., Van Broeckhoven, C., Bigio, E.H., Deng, H.X., Halliday, G.M., Kril, J.J., Munoz, D.G., Mann, D.M., Pickering-Brown, S.M., Doodeman, V., Adamson, G., Ghazi-Noori, S., Fisher, E.M., Holton, J.L., Revesz, T., Rossor, M.N., Collinge, J., Mead, S., Isaacs, A.M., FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 120 (2010), 33–41.
36. [36] Neumann, M., Rademakers, R., Roeber, S., Baker, M., Kretzschmar, H.A., Mackenzie, I.R., A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain J. Neurol. 132 (2009), 2922–2931.
37. [37] Sun, S., Ling, S.C., Qiu, J., Albuquerque, C.P., Zhou, Y., Tokunaga, S., Li, H., Qiu, H., Bui, A., Yeo, G.W., Huang, E.J., Eggan, K., Zhou, H., Fu, X.D., Lagier-Tourenne, C., Cleveland, D.W., ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat. Commun., 6, 2015, 6171.
38. [38] Armstrong, G.A., Drapeau, P., Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS. Hum. Mol. Genet. 22 (2013), 4282–4292.
39. [39] Kim, H.J., Kim, N.C., Wang, Y.D., Scarborough, E.A., Moore, J., Diaz, Z., MacLea, K.S., Freibaum, B., Li, S., Molliex, A., Kanagaraj, A.P., Carter, R., Boylan, K.B., Wojtas, A.M., Rademakers, R., Pinkus, J.L., Greenberg, S.A., Trojanowski, J.Q., Traynor, B.J., Smith, B.N., Topp, S., Gkazi, A.S., Miller, J., Shaw, C.E., Kottlors, M., Kirschner, J., Pestronk, A., Li, Y.R., Ford, A.F., Gitler, A.D., Benatar, M., King, O.D., Kimonis, V.E., Ross, E.D., Weihl, C.C., Shorter, J., Taylor, J.P., Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495 (2013), 467–473.
40. [40] Johnson, J.O., Pioro, E.P., Boehringer, A., Chia, R., Feit, H., Renton, A.E., Pliner, H.A., Abramzon, Y., Marangi, G., Winborn, B.J., Gibbs, J.R., Nalls, M.A., Morgan, S., Shoai, M., Hardy, J., Pittman, A., Orrell, R.W., Malaspina, A., Sidle, K.C., Fratta, P., Harms, M.B., Baloh, R.H., Pestronk, A., Weihl, C.C., Rogaeva, E., Zinman, L., Drory, V.E., Borghero, G., Mora, G., Calvo, A., Rothstein, J.D., Drepper, C., Sendtner, M., Singleton, A.B., Taylor, J.P., Cookson, M.R., Restagno, G., Sabatelli, M., Bowser, R., Chio, A., Traynor, B.J., Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 17 (2014), 664–666.
41. [41] Abisambra, J., Jinwal, U.K., Miyata, Y., Rogers, J., Blair, L., Li, X., Seguin, S.P., Wang, L., Jin, Y., Bacon, J., Brady, S., Cockman, M., Guidi, C., Zhang, J., Koren, J., Young, Z.T., Atkins, C.A., Zhang, B., Lawson, L.Y., Weeber, E.J., Brodsky, J.L., Gestwicki, J.E., Dickey, C.A., Allosteric heat shock protein 70 inhibitors rapidly rescue synaptic plasticity deficits by reducing aberrant tau. Biol. Psychiatry 74 (2013), 367–374.
42. [42] Tanaka, M., Gupta, R., Mayer, B.J., Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins. Mol. Cell. Biol. 15 (1995), 6829–6837.
43. [43] Zhai, J., Strom, A.L., Kilty, R., Venkatakrishnan, P., White, J., Everson, W.V., Smart, E.J., Zhu, H., Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cord. FEBS J. 276 (2009), 3308–3323.
44. [44] UniProt, C., UniProt: a hub for protein information. Nucleic Acids Res. 43 (2015), D204–D212.
45. [45] Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K.P., Kuhn, M., Bork, P., Jensen, L.J., von Mering, C., STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43 (2015), D447–D452.
46. [46] Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., von Mering, C., Jensen, L.J., STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41 (2013), D808–D815.
47. [47] Jurica, M.S., Licklider, L.J., Gygi, S.R., Grigorieff, N., Moore, M.J., Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. RNA 8 (2002), 426–439.
48. [48] Will, C.L., Urlaub, H., Achsel, T., Gentzel, M., Wilm, M., Luhrmann, R., Characterization of novel SF3b and 17S U2 snRNP proteins, including a human Prp5p homologue and an SF3b DEAD-box protein. EMBO J. 21 (2002), 4978–4988.
49. [49] Will, C.L., Schneider, C., Hossbach, M., Urlaub, H., Rauhut, R., Elbashir, S., Tuschl, T., Luhrmann, R., The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome. RNA 10 (2004), 929–941.
50. [50] Popow, J., Englert, M., Weitzer, S., Schleiffer, A., Mierzwa, B., Mechtler, K., Trowitzsch, S., Will, C.L., Luhrmann, R., Soll, D., Martinez, J., HSPC117 is the essential subunit of a human tRNA splicing ligase complex. Science 331 (2011), 760–764.
51. [51] Jonson, L., Vikesaa, J., Krogh, A., Nielsen, L.K., Hansen, T., Borup, R., Johnsen, A.H., Christiansen, J., Nielsen, F.C., Molecular composition of IMP1 ribonucleoprotein granules. Mol. Cell. Proteomics 6 (2007), 798–811.
52. [52] Weidensdorfer, D., Stohr, N., Baude, A., Lederer, M., Kohn, M., Schierhorn, A., Buchmeier, S., Wahle, E., Huttelmaier, S., Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. RNA 15 (2009), 104–115.
53. [53] Kanai, Y., Dohmae, N., Hirokawa, N., Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 43 (2004), 513–525.
54. [54] Brendel, C., Rehbein, M., Kreienkamp, H.J., Buck, F., Richter, D., Kindler, S., Characterization of Staufen 1 ribonucleoprotein complexes. Biochem. J. 384 (2004), 239–246.
55. [55] Villace, P., Marion, R.M., Ortin, J., The composition of Staufen-containing RNA granules from human cells indicates their role in the regulated transport and translation of messenger RNAs. Nucleic Acids Res. 32 (2004), 2411–2420.
56. [56] Hoek, K.S., Kidd, G.J., Carson, J.H., Smith, R., hnRNP A2 selectively binds the cytoplasmic transport sequence of myelin basic protein mRNA. Biochemistry 37 (1998), 7021–7029.
57. [57] Solomon, S., Xu, Y., Wang, B., David, M.D., Schubert, P., Kennedy, D., Schrader, J.W., Distinct structural features of caprin-1 mediate its interaction with G3BP-1 and its induction of phosphorylation of eukaryotic translation initiation factor 2alpha, entry to cytoplasmic stress granules, and selective interaction with a subset of mRNAs. Mol. Cell. Biol. 27 (2007), 2324–2342.
58. [58] Aulas, A., Vande Velde, C., Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS?. Front. Cell. Neurosci., 9, 2015, 423.
59. [59] Burgess, H.M., Richardson, W.A., Anderson, R.C., Salaun, C., Graham, S.V., Gray, N.K., Nuclear relocalisation of cytoplasmic poly(A)-binding proteins PABP1 and PABP4 in response to UV irradiation reveals mRNA-dependent export of metazoan PABPs. J. Cell Sci. 124 (2011), 3344–3355.
60. [60] Wilczynska, A., Aigueperse, C., Kress, M., Dautry, F., Weil, D., The translational regulator CPEB1 provides a link between dcp1 bodies and stress granules. J. Cell Sci. 118 (2005), 981–992.
61. [61] Meister, G., Landthaler, M., Peters, L., Chen, P.Y., Urlaub, H., Luhrmann, R., Tuschl, T., Identification of novel argonaute-associated proteins. Curr. Biol. 15 (2005), 2149–2155.
62. [62] Kedersha, N., Stoecklin, G., Ayodele, M., Yacono, P., Lykke-Andersen, J., Fritzler, M.J., Scheuner, D., Kaufman, R.J., Golan, D.E., Anderson, P., Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J. Cell Biol. 169 (2005), 871–884.
63. [63] Borggrefe, T., Wabl, M., Akhmedov, A.T., Jessberger, R., A B-cell-specific DNA recombination complex. J. Biol. Chem. 273 (1998), 17025–17035.
64. [64] Guil, S., Long, J.C., Caceres, J.F., hnRNP A1 relocalization to the stress granules reflects a role in the stress response. Mol. Cell. Biol. 26 (2006), 5744–5758.
65. [65] Sama, R.R., Ward, C.L., Kaushansky, L.J., Lemay, N., Ishigaki, S., Urano, F., Bosco, D.A., FUS/TLS assembles into stress granules and is a prosurvival factor during hyperosmolar stress. J. Cell. Physiol. 228 (2013), 2222–2231.
66. [66] Gomes, C., Keller, S., Altevogt, P., Costa, J., Evidence for secretion of Cu, Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neurosci. Lett. 428 (2007), 43–46.
67. [67] Grad, L.I., Yerbury, J.J., Turner, B.J., Guest, W.C., Pokrishevsky, E., O'Neill, M.A., Yanai, A., Silverman, J.M., Zeineddine, R., Corcoran, L., Kumita, J.R., Luheshi, L.M., Yousefi, M., Coleman, B.M., Hill, A.F., Plotkin, S.S., Mackenzie, I.R., Cashman, N.R., Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 3620–3625.
68. [68] Ding, X., Ma, M., Teng, J., Teng, R.K., Zhou, S., Yin, J., Fonkem, E., Huang, J.H., Wu, E., Wang, X., Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure. Oncotarget 6 (2015), 24178–24191.
69. [69] Feiler, M.S., Strobel, B., Freischmidt, A., Helferich, A.M., Kappel, J., Brewer, B.M., Li, D., Thal, D.R., Walther, P., Ludolph, A.C., Danzer, K.M., Weishaupt, J.H., TDP-43 is intercellularly transmitted across axon terminals. J. Cell Biol. 211 (2015), 897–911.
70. [70] Pokrishevsky, E., Grad, L.I., Cashman, N.R., TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion. Sci. Rep., 6, 2016, 22155.
71. [71] Ulke-Lemee, A., Trinkle-Mulcahy, L., Chaulk, S., Bernstein, N.K., Morrice, N., Glover, M., Lamond, A.I., Moorhead, G.B., The nuclear PP1 interacting protein ZAP3 (ZAP) is a putative nucleoside kinase that complexes with SAM68, CIA, NF110/45, and HNRNP-G. Biochim. Biophys. Acta 1774 (2007), 1339–1350.
72. [72] Ting, N.S., Kao, P.N., Chan, D.W., Lintott, L.G., Lees-Miller, S.P., DNA-dependent protein kinase interacts with antigen receptor response element binding proteins NF90 and NF45. J. Biol. Chem. 273 (1998), 2136–2145.
73. [73] Deng, Q., Holler, C.J., Taylor, G., Hudson, K.F., Watkins, W., Gearing, M., Ito, D., Murray, M.E., Dickson, D.W., Seyfried, N.T., Kukar, T., FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage. J. Neurosci. 34 (2014), 7802–7813.
74. [74] Perez-Gonzalez, A., Pazo, A., Navajas, R., Ciordia, S., Rodriguez-Frandsen, A., Nieto, A., hCLE/C14orf166 associates with DDX1-HSPC117-FAM98B in a novel transcription-dependent shuttling RNA-transporting complex. PLoS One, 9, 2014, e90957.
75. [75] Nielsen, J., Christiansen, J., Lykke-Andersen, J., Johnsen, A.H., Wewer, U.M., Nielsen, F.C., A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol. Cell. Biol. 19 (1999), 1262–1270.
76. [76] Patel, G.P., Ma, S., Bag, J., The autoregulatory translational control element of poly(A)-binding protein mRNA forms a heteromeric ribonucleoprotein complex. Nucleic Acids Res. 33 (2005), 7074–7089.
77. [77] Prokipcak, R.D., Herrick, D.J., Ross, J., Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA. J. Biol. Chem. 269 (1994), 9261–9269.
78. [78] Donnelly, C.J., Willis, D.E., Xu, M., Tep, C., Jiang, C., Yoo, S., Schanen, N.C., Kirn-Safran, C.B., van Minnen, J., English, A., Yoon, S.O., Bassell, G.J., Twiss, J.L., Limited availability of ZBP1 restricts axonal mRNA localization and nerve regeneration capacity. EMBO J. 30 (2011), 4665–4677.
79. [79] Kedersha, N., Anderson, P., Mammalian stress granules and processing bodies. Methods Enzymol. 431 (2007), 61–81.
80. [80] Sheth, U., Parker, R., Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 300 (2003), 805–808.
81. [81] Aulas, A., Stabile, S., Vande Velde, C., Endogenous TDP-43, but not FUS, contributes to stress granule assembly via G3BP. Mol. Neurodegener., 7, 2012, 54.
82. [82] Li, Y.R., King, O.D., Shorter, J., Gitler, A.D., Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 201 (2013), 361–372.
83. [83] Bentmann, E., Haass, C., Dormann, D., Stress granules in neurodegeneration—lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma. FEBS J. 280 (2013), 4348–4370.
84. [84] Blokhuis, A.M., Koppers, M., Groen, E.J., van den Heuvel, D.M., Dini Modigliani, S., Anink, J.J., Fumoto, K., van Diggelen, F., Snelting, A., Sodaar, P., Verheijen, B.M., Demmers, J.A., Veldink, J.H., Aronica, E., Bozzoni, I., den Hertog, J., van den Berg, L.H., Pasterkamp, R.J., Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Acta Neuropathol., 2016.